Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-041618)

Filing Details

Accession Number:: 0001104659-21-041618
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-25 18:13:49
Reporting Period:: 2021-03-23

Accepted Time:: 2021-03-25 18:13:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1760542	Hookipa Pharma Inc.	HOOK	()	XX

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1441261	Fcpr Vi Capital Sofinnova	C/O Hookipa Pharma Inc., 350 Fifth, Avenue, 72Nd Floor, Suite 7240 New York, NY 10118		No	No	Yes	No
1574139	Sas Partners Sofinnova	C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York, NY 10118		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-23	40,000	$13.91	3,659,430	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.